
Ibex Medical Analytics
HealthTech & Life SciencesIbex Medical Analytics develops AI-assisted pathology software for reviewing digitised tissue slides.
Introduce me to Ibex Medical Analytics
Image source: company website sharing image
Founders & company facts
Sources reviewed:Reported cumulative funding
$116,600,000 · Source
This index includes companies with publicly reported total funding up to US$150 million. This is a reported total, not valuation, the latest round size or confirmation of an open round. Funding reviewed: .
Documented founding team
- Joseph (Yossi) MosselSource: Joseph (Yossi) Mossel
- Chaim LinhartSource: Chaim Linhart
- Founded
- 2016Source
- Reported Israeli location
- Tel Aviv-YafoSource
- Team range in directory
- 51-200Source
- Reported business model
- B2BSource
Selected disclosed financing
Selected transactions, with dates, funding types and reported participants.
- Sept 2023$55MSeries CNamed participants
83North · Sienna Venture Capital · aMoon Fund · Planven Entrepreneur Ventures · Dell Technologies Capital · Octopus Ventures
Source - Nov 2022$10MUnspecified round
Company overview
Product & customers
Ibex Medical Analytics develops AI-assisted pathology software for reviewing digitised tissue slides. Its platform supports pathologists in identifying cancer-related and other diagnostic features, and the company also describes applications in biomarker research and drug development.
Commercial potential · editorial analysis
Pathology digitisation creates an opening for software that assists repetitive review and quality assurance. Multiple tissue types and research uses may broaden demand, provided the product fits laboratory routines and delivers dependable clinical support.
What to validate
Review evidence by tissue type, authorisation scope and performance on external datasets. Scanner compatibility, false findings, clinician acceptance and the cost of implementation are necessary to understand how technical capability becomes recurring revenue.
Product source reviewed on . Company source